Stockscreener 앱 받기
11.14
0.27%
0.03
시장 영업 전:
10.99
-0.15
-1.35%
전일 마감가:
$11.11
열려 있는:
$11.08
하루 거래량:
496.48K
Relative Volume:
0.49
시가총액:
$1.05B
수익:
$174.54M
순이익/손실:
$6.03M
주가수익비율:
139.25
EPS:
0.08
순현금흐름:
$15.96M
1주 성능:
-0.18%
1개월 성능:
-2.96%
6개월 성능:
+24.19%
1년 성능:
+21.09%
1일 변동 폭
$11.07
$11.17
1주일 범위
$11.03
$11.20
52주 변동 폭
$7.83
$11.80
Enfusion Inc Stock (ENFN) Company Profile
명칭
Enfusion Inc
전화
(312) 253-9800
주소
125 SOUTH CLARK STREET, SUITE 750, CHICAGO
ENFN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ENFN
Enfusion Inc
|
11.14 | 1.05B | 174.54M | 6.03M | 15.96M | 0.08 |
|
SAP
Sap Se Adr
|
271.42 | 316.61B | 36.97B | 3.37B | 4.79B | 2.8498 |
|
CRM
Salesforce Inc
|
271.54 | 259.66B | 37.90B | 6.20B | 12.43B | 6.36 |
|
INTU
Intuit Inc
|
620.91 | 171.59B | 17.17B | 3.04B | 5.63B | 10.72 |
|
NOW
Servicenow Inc
|
824.03 | 167.58B | 10.98B | 1.43B | 3.38B | 6.83 |
|
ADBE
Adobe Inc
|
385.78 | 164.42B | 22.04B | 6.75B | 9.19B | 15.18 |
Enfusion Inc Stock (ENFN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-05-10 | 재개 | Morgan Stanley | Overweight |
| 2024-02-28 | 다운그레이드 | Goldman | Neutral → Sell |
| 2024-01-30 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2023-11-07 | 개시 | UBS | Neutral |
| 2023-04-03 | 개시 | Piper Sandler | Neutral |
| 2023-03-15 | 개시 | JP Morgan | Neutral |
| 2023-01-04 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2023-01-03 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-03 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2021-11-15 | 개시 | BofA Securities | Buy |
| 2021-11-15 | 개시 | Credit Suisse | Neutral |
| 2021-11-15 | 개시 | Goldman | Neutral |
| 2021-11-15 | 개시 | Morgan Stanley | Equal-Weight |
| 2021-11-15 | 개시 | Piper Sandler | Overweight |
| 2021-11-15 | 개시 | Stifel | Buy |
| 2021-11-15 | 개시 | William Blair | Outperform |
모두보기
Enfusion Inc 주식(ENFN)의 최신 뉴스
Clearwater Analytics and Enfusion Announce Election Deadline for Enfusion Shareholders to Elect Form of Merger Consideration - 01net
Critical Merger Deadline: Enfusion Shareholders Must Choose Payment Type by April 16 - Stock Titan
ENFUSION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enfusion, Inc.ENFN - Business Wire
Learn to Evaluate (ENFN) using the Charts - news.stocktradersdaily.com
Shareholder Rights Advocates at Levi & Korsinsky Investigate Enfusion, Inc. (ENFN) Regarding Possible Securities Fraud Violations - ACCESS Newswire
Lost Money on Enfusion, Inc. (ENFN)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - ACCESS Newswire
Bank of New York Mellon Corp Increases Stock Holdings in Enfusion, Inc. (NYSE:ENFN) - Defense World
MS cuts rating on Enfusion stock after Clearwater’s acquisition bid - MSN
(ENFN) Trading Report - Stock Traders Daily
Enfusion, Inc. Reports Strong Growth Amid Acquisition Plans - MSN
Enfusion (ENFN) to Release Earnings on Tuesday - Defense World
Enfusion CEO Oleg Movchan sells $130,472 in stock By Investing.com - Investing.com South Africa
Rhumbline Advisers Has $643,000 Stake in Enfusion, Inc. (NYSE:ENFN) - Defense World
Enfusion’s chief people officer sells shares worth $35,558 - Investing.com India
Enfusion CFO sells $52,836 in stock to cover tax obligations By Investing.com - Investing.com Canada
Enfusion Executives Cash In: Major Stock Sales Unveiled! - TipRanks
Enfusion chief accounting officer sells $6,165 in stock By Investing.com - Investing.com Canada
Enfusion’s general counsel Matthew Campobasso sells $19,280 in stock - Investing.com
Enfusion chief accounting officer sells $6,165 in stock - Investing.com
Enfusion COO Neal Pawar sells $165,620 in stock - Investing.com
Enfusion’s chief people officer sells shares worth $35,558 By Investing.com - Investing.com South Africa
Enfusion Executives Sell Shares to Cover Tax Obligations - TradingView
Enfusion’s Hold Rating: Balancing Strategic Merger Benefits with Market Uncertainties - TipRanks
Enfusion CEO Oleg Movchan sells $130,472 in stock - Investing.com
Enfusion’s CAO Makes a Noteworthy Stock Sale! - TipRanks
Enfusion’s general counsel sells $12,410 in stock to cover taxes By Investing.com - Investing.com South Africa
Enfusion COO Neal Pawar sells $31,790 in stock - Investing.com India
Enfusion Executives Unload Major Stock Holdings! - TipRanks
Enfusion COO Neal Pawar sells $31,790 in stock By Investing.com - Investing.com Canada
Enfusion chief accounting officer sells $2,514 in stock - Investing.com Australia
Enfusion chief accounting officer sells $2,514 in stock By Investing.com - Investing.com South Africa
Enfusion CEO Oleg Movchan sells $32,031 in stock By Investing.com - Investing.com Canada
Enfusion CFO Bradley Herring sells $17,600 in stock By Investing.com - Investing.com South Africa
Enfusion’s chief people officer sells shares worth $23,696 - Investing.com India
Enfusion CEO Oleg Movchan sells $32,031 in stock - Investing.com
Enfusion’s chief people officer sells shares worth $23,696 By Investing.com - Investing.com South Africa
Stifel maintains Enfusion stock Hold rating, $11.25 target By Investing.com - Investing.com Canada
Stifel maintains Enfusion stock Hold rating, $11.25 target - Investing.com India
Enfusion, Inc. (ENFN) Lags Q4 Earnings and Revenue Estimates - MSN
Enfusion earnings missed by $0.03, revenue fell short of estimates - Investing.com Canada
Enfusion Q4 Adjusted Earnings Fall, Revenue Rises -March 03, 2025 at 05:38 pm EST - Marketscreener.com
Enfusion Announces Fourth Quarter and Full Year 2024 Results - TradingView
Earnings Flash (ENFN) ENFUSION INC. Reports Q4 Revenue $52.9M, vs. FactSet Est of $54.3M - Marketscreener.com
Enfusion Inc (ENFN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.72%
자본화:
|
볼륨(24시간):